Joseph A. Bocchini, Jr., M.D.
Louisiana State University Health Sciences Center in Shreveport
Dr. Bocchini is Professor of Pediatrics and Chairman of the Department of Pediatrics at Louisiana State University Health Sciences Center in Shreveport where he also serves as Medical Director of the Children’s Hospital and as a member of the Section of Pediatric Infectious Diseases. Dr. Bocchini received his M.D. from St. Louis University School of Medicine. He completed a residency in Pediatrics at the University of Connecticut and a fellowship in Pediatric Infectious Diseases at the Johns Hopkins University. He joined the faculty at LSUHSC in Shreveport in 1977. Dr. Bocchini is a member of the American Society of Microbiology, Infectious Diseases Society of America, the Pediatric Infectious Diseases Society the American Pediatric Society and the Ambulatory Pediatric Association. He is a member of the Editorial Board of the Pediatric Infection Disease Journal.
Dr. Bocchini’s research interests have included infectious diseases, vaccines, vaccine risk/benefit communication and doctor/patient communication. He has served as a member of the American Academy of Pediatrics Committee on Infectious Diseases (COID) since 2002 and since 2006 has served as Chairperson of the COID. In that capacity, he has represented the AAP on the Secretary’s Advisory Committee for Immunization Practices (ACIP) of the Centers for Disease Control and as liaison to the ACIP Working Group on Human Papillomavirus Vaccine. He has been involved in policy development for pediatric vaccines and in development of the 2009 edition of the AAP’s Red Book (2009 Report of the Committee on Infectious Diseases). Dr. Bocchini has participated as a medical liaison in a HRSA funded project on development of model policies and procedures and minimum standards for state newborn genetic screening programs for the informed consent process and as co-investigator on a HRSA grant on physician education and training regarding newborn screening. Dr. Bocchini served as a member of the Louisiana Birth Defects Registry Task Force from 1999-2001 and has been a member of the Louisiana Newborn Screening Committee since 2002.
Charles Homer, M.D., M.P.H.
National Initiative for Children's Healthcare Quality
Dr. Charles Homer co-founded the National Initiative for Children's Healthcare Quality in July 1999 and he currently serves as the organization's President and CEO. He is an associate professor of the Department of Society, Human Development and Health at the Harvard University School of Public Health and an associate clinical professor of pediatrics at Harvard Medical School. He was a member of the third US Preventive Services Task Force from 2000-2002 and served as chair of the American Academy of Pediatrics Committee on Quality Improvement from 1999-2001 and its Steering Committee on Quality Improvement and Management from 2001-2004. He obtained his bachelor’s degree from Yale University, his medical degree from the University of Pennsylvania, and a master’s degree in public health from the University of North Carolina at Chapel Hill. Dr. Homer serves as a member of the Institute of Medicine's Pediatric Health and Quality Measurement Committee specified in the 2009 CHIPRA legislation; chairs the Children’s Measurement Advisory Panel for NCQA; and co-chaired the National Quality Forum (NQF) Child Outcomes Steering Committee from 2009-2010. He is a technical advisor to the Patent Centered Medical Home Initiative of the Commonwealth of Massachusetts, and also serves on the Performance Measurement Expert Panel of the Commonwealth of Massachusetts’ Health Care Quality and Cost Council (HCQCC).
Stephen McDonough, M.D.
Medicenter One Health Systems, Inc.- General Pediatrician
Stephen McDonough M.D. is a board certified pediatrician who has worked in the rural State of North Dakota for 30 years. He attended the University of Minnesota Medical School and completed his pediatric residency at the University of Colorado in Denver. He worked for 15 years at the North Dakota Department of Health where he served as the medical director for newborn metabolic screening. When the North Dakota Legislature passed a law adding galactosemia screening, Governor George Sinner asked Dr. McDonough to investigate collaboration with other States. Dr. McDonough led the effort to have the Iowa Metabolic Screening program to perform newborn testing for North Dakota newborns. Dr. McDonough is in private practice in Bismarck and sees numerous children with metabolic and genetic diseases.
Dietrich Matern, M.D.
Dietrich Matern, M.D. is an associate professor of laboratory medicine at the Mayo Clinic College of Medicine. Prior to coming to Minnesota, he completed a pediatric residency in his native Germany (Albert-Ludwigs-University, Freiburg, 1992-97) and genetics fellowships at Duke University (1997-1999). He serves as co-director of the Biochemical Genetics Laboratory in the Department of Laboratory Medicine and Pathology and holds joint appointments in the Department of Pediatric & Adolescent Medicine and in the Department of Medical Genetics. Dr. Matern has a special interest in the early diagnosis of inborn errors of metabolism, particularly by application of tandem mass spectrometry. In the area of newborn screening, he is interested in the reduction of false positive results by second-tier assays using the original newborn screening blood spot sample and in determining the most efficient and effective approach to expand newborn screening to include lysosomal storage and other disorders.
Catherine A. L. Wicklund, M.S., C.G.C.
Catherine A. L. Wicklund, M.S., C.G.C., received her Bachelor of Science degree in biology from the University of Wisconsin-River Falls and a Master of Science degree in genetic counseling from the Graduate Program in Genetic Counseling at the University of Texas Graduate School in Biomedical Sciences at Houston in 1993. She was the director of Prenatal Genetic Counseling Services at the University of Texas Medical School-Department of Obstetrics, Gynecology & Reproductive Sciences, in addition to being the co-director of the Graduate Program in Genetic Counseling. She is currently the director of the Northwestern Graduate Program in Genetic Counseling. In addition, she provides prenatal genetic counseling services in the Department of Obstetrics and Gynecology. As President of the National Society of Genetic Counselors, she has represented the organization at several national committees including the Secretary’s Advisory Committee on Genetics, Health and Society and she is a member of the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health. She is also active on a state level, working with the Illinois Department of Public Health on genetics education and finance and reimbursement issues, and as a member of the Genetic and Metabolic Diseases Advisory Committee. Her research interests include cross-cultural communication, psychosocial and counseling issues, prenatal diagnosis, decision making, billing and reimbursement and delivery of genetic services.
Andrea M. Williams, B.A.
The Children’s Sickle Cell Foundation, Inc.
Andrea M. Williams, B.A., is the founding Executive director of The Children’s Sickle Cell Foundation, Inc., an organization committed to the well-being of children with sickle cell disease and their families. CSCF, Inc. is a leader in the community and corporate education for sickle cell disease (SCD) and sickle cell trait (SCT) directed at those who are most at risk. Ms. Williams has been active in advocacy for newborn screening testing and follow-up for Hemoglobinopathies and other genetic disorders. At the local, regional and national level she regularly interacts with opinion leaders at the governmental, legislature and executive levels. She is a member of SACHDNC’s Education and Training Subcommittee and has been involved in a variety of issues including engaging the health care providers in the process of newborn screening, educational messages for the general public, carrier identification and follow-up. She has made public comments to the full committee on behalf of sickle cell disease and offered consumer perspectives for the long term follow-up subcommittee. Ms. Williams is also active on a workgroup for the Genetic Alliance that reviews issues of the Advisory Committee.